Biorepository for Precision Genomics
NCT02587026 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 480
Last updated 2020-11-13
Summary
This is a tissue collection protocol to create an annotated biorepository to support future basic and translational research. The study protocol and consent will request patient permission to allow their specimens to be stored for future use in other laboratory/correlative studies without requiring a separate new consent at a future date. It will include also a retrospective review of all patients who have been seen or treated by the Precision Genomics Clinic (waiver of consent requested). No specific research studies/aims are included directly in this proposal. Use of the samples, data, and other resources (cell lines, etc.) created within this protocol will require review/approval by the majority of the Precision Genomics Investigators and appropriate IRB approval.
Conditions
- Neoplasms
Interventions
- OTHER
-
Blood sample collection
- OTHER
-
Tumor tissue sample collection
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Bryan P Schneider, MD · Vera Bradley Professor of Oncology, Professor of Medicine, Professor of Medical & Molecular Genetics
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-27
- Primary Completion
- 2020-07-07
- Completion
- 2020-07-07
Countries
- United States
Study Locations
More Related Trials
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Concordance Between ctDNA Assay and FoundationOne
NCT02620527 ·Status: COMPLETED
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
NCT00899990 ·Status: COMPLETED
-
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
NCT02628379 ·Status: COMPLETED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045 ·Status: TERMINATED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Penn Biobank Return of Research Results Program
NCT04242667 ·Status: COMPLETED ·Phase: NA
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT06896162 ·Status: RECRUITING ·Phase: NA
-
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
NCT02549638 ·Status: TERMINATED
-
Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples
NCT02239575 ·Status: WITHDRAWN
-
Genomic Profiling Assay in Phase I
NCT02437617 ·Status: COMPLETED
-
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
NCT03553550 ·Status: TERMINATED
-
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
NCT00897767 ·Status: COMPLETED
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
NCT02297087 ·Status: TERMINATED ·Phase: NA